This is a medicine used to treat certain types of inflammatory bowel disease, like Crohn's disease and ulcerative colitis. It works by reducing inflammation in the digestive tract. It's often taken as a pill or liquid.
Every report comes from a Lived member, sent anonymously.
Have you tried Sulfasalazine for Rheumatoid Arthritis?
Sulfasalazine is a long-established anti-inflammatory medicine for ulcerative colitis and inflammatory arthritis. In the US it is sold as Azulfidine (standard tablets) and Azulfidine EN-tabs (delayed-release tablets), as well as generic versions of both. Both forms are approved to treat mild to moderate ulcerative colitis, a condition in which the lining of the colon and rectum becomes inflamed and ulcerated, and as an add-on treatment in severe flares. Taken over the long term, they also help keep the disease in remission between flares. Only the delayed-release form is also approved for rheumatoid arthritis in adults and for polyarticular juvenile idiopathic arthritis (arthritis affecting many joints) in children 6 and older, in each case when anti-inflammatory pain relievers such as ibuprofen have not been enough. For rheumatoid arthritis, US rheumatology guidelines usually prefer methotrexate as the first disease-modifying medicine, so sulfasalazine is more often an alternative or part of a combination. It is sometimes tried for Crohn's disease, but trials have not shown a clear benefit for it there.
Sulfasalazine is two drugs joined together: 5-aminosalicylic acid (5-ASA, also called mesalamine), an anti-inflammatory compound, and sulfapyridine, a sulfa drug. Most of a dose passes through the stomach and small intestine intact. Bacteria in the colon then split it into its two parts. This delivery explains much of how it is used. In ulcerative colitis, most of the benefit appears to come from the 5-ASA released right where the inflammation is. Sulfapyridine is absorbed into the bloodstream and causes many of the side effects. In arthritis it is not known which part does the work, but the medicine calms the immune-driven inflammation that damages joints. It is a slow-acting, disease-modifying treatment rather than a pain reliever, so it does not ease symptoms right away.
Sulfasalazine is taken by mouth several times a day, in evenly divided doses, preferably after meals. Delayed-release tablets should be swallowed whole, not crushed or chewed, because the coating protects the stomach. Drinking plenty of fluids helps prevent crystals or stones forming in the urine. Prescribers usually start with a low dose and increase it over the first few weeks, which makes nausea and stomach upset less likely. In ulcerative colitis, the dose is often higher during a flare and is then lowered to a maintenance dose once the disease settles. In arthritis, the dose is built up over about four weeks to a steady daily amount. Children's doses are based on body weight. Follow the schedule on the prescription rather than adjusting it yourself.
Loss of appetite, nausea, stomach upset, vomiting and headache are the most common side effects, especially early on or at higher doses. Starting low, taking doses after food or switching to the delayed-release tablets often helps. Sulfasalazine can also turn urine, and sometimes skin, an orange-yellow color. This is expected and harmless. Rarely, sulfasalazine causes serious drops in blood cells or liver injury. Contact your care team promptly about a sore throat, fever, pale skin, unusual bruising or tiny purple spots, or yellowing of the skin or eyes. You may be asked to pause the medicine until blood tests come back. Severe allergic reactions affecting the skin and internal organs are uncommon but serious, and most happen in the first month. Stop taking it and get medical care right away for a spreading rash, blistering or peeling skin, mouth sores, or fever with swollen glands.
Sulfasalazine should not be used by people who are allergic to it, to sulfa drugs (sulfonamides, a group that includes some antibiotics) or to salicylates such as aspirin. It is also not used in people with a blockage of the bowel or urinary tract, or with porphyria, a rare inherited blood disorder that sulfa drugs can trigger. People with liver or kidney disease, existing blood disorders, severe allergies or asthma, or frequent infections need careful assessment first. People with G6PD (glucose-6-phosphate dehydrogenase) deficiency, an inherited enzyme shortage, are watched for anemia caused by red blood cells breaking down. Sulfasalazine reduces how well the body absorbs folic acid, so many people take a folic acid supplement alongside it. It can also lower the absorption of digoxin, a heart medicine. Combined with methotrexate, it causes more nausea than either alone. Sulfasalazine is generally considered compatible with pregnancy, together with folic acid supplementation before conception and in early pregnancy. Anyone pregnant or planning pregnancy should discuss the folic acid dose with their care team. It passes into breast milk and is usually acceptable for healthy, full-term babies, but a breastfed baby who develops diarrhea or bloody stools should be checked. In men, it can lower sperm count and fertility. This reverses after stopping.
Sulfasalazine works gradually. In rheumatoid arthritis, some people notice improvement after about four weeks, but it can take up to 12 weeks to judge whether it is helping, so pain relievers are often continued in the meantime. In ulcerative colitis, the care team judges response by changes in diarrhea, bleeding, weight and sometimes a scope examination, and lowers the dose once the disease is under control. Blood tests are a routine part of treatment. Blood counts and liver tests are done before starting, every two weeks for the first three months, monthly for the next three months, then about every three months. Urine and kidney function are checked from time to time as well. Most serious problems appear early, which is why testing is most frequent then. Both ulcerative colitis and rheumatoid arthritis rarely go away completely, so sulfasalazine is usually a long-term medicine. Staying on it after symptoms improve lowers the chance of an ulcerative colitis flare returning. If it is not effective enough or not tolerated, there are several other options, and it is sometimes combined with other medicines.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Sulfasalazine, what you've noticed, or ask the community a question.